476 related articles for article (PubMed ID: 34196310)
1. Targeting the gut to treat multiple sclerosis.
Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
[TBL] [Abstract][Full Text] [Related]
2. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.
Dziedzic A; Saluk J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430954
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
6. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases.
Ghezzi L; Cantoni C; Rotondo E; Galimberti D
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884791
[TBL] [Abstract][Full Text] [Related]
9. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.
Gerhardt S; Mohajeri MH
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583
[TBL] [Abstract][Full Text] [Related]
10. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
Kumar N; Sahoo NK; Mehan S; Verma B
Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
[TBL] [Abstract][Full Text] [Related]
11. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
13. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
[TBL] [Abstract][Full Text] [Related]
15. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
16. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.
Camara-Lemarroy CR; Metz LM; Yong VW
World J Gastroenterol; 2018 Oct; 24(37):4217-4223. PubMed ID: 30310254
[TBL] [Abstract][Full Text] [Related]
17. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System.
Obata Y; Pachnis V
Gastroenterology; 2016 Nov; 151(5):836-844. PubMed ID: 27521479
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
20. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
